Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT01510067
- Status
- Recruiting
Conditions
- Cutaneous Lupus Erythematosus (CLE)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Texas Southwestern (UTSW).
Key Dates
- Start date
- Dec 31, 2006
- Status verified
- Mar 2026
- Primary completion
- Jan 2, 2030
- Completion
- Jan 2, 2030
Study Design
- Enrollment
- 700 participants (estimated)
Central Contacts
- Victoria P Werth, MD215-615-2940
- Joyce Okawa, R.N215-615-2940
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | |
| University of Texas Southwestern | Dallas | Texas | 75390 | Benjamin Chong |
Find similar trials in Philadelphia, PA
Related Studies
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus ErythematosusPHASE2 · Recruiting · Ventus Therapeutics U.S., Inc. · Beverly Hills, California
- A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseasePHASE3 · Recruiting · EMD Serono Research & Development Institute, Inc. · Los Angeles, California
- Research Accelerated by You Lupus RegistryRecruiting · Lupus Foundation of America · Washington D.C., District of Columbia